The inhibition of EphB3 expression resulted in reduced ESCC cell proliferation, migration, invasion, and tumor growth via the dysregulation of the epithelial-mesenchymal transition process [14]. This evidence concerns the gene EPHB3 and esophageal squamous cell carcinoma.